Masimo (NSDQ:MASI) announced today that its study of the Masimo Patient SafetyNet and rainbow acoustic monitoring (RAM) with RRa revealed that use of monitoring systems might provide a safety net for postoperative patients. Irvine, Calif.-based Masimo’s Patient SafetyNet is a supplemental remote monitoring patient surveillance and clinician notification system designed to work with Masimo and third-party […]
Masimo shares drop after bottom-line slide, company’s Radius Capnography wins CE Mark
Masimo (NSDQ:MASI) shares are down today after a slide on third-quarter profits, despite an increase in sales revenue. Irvine, Calif.-based Masimo posted profits of $49.1 million, or 86¢ per share, on sales of $228.9 million for the three months ended Sept. 30, for a bottom-line slide of -14.1% on revenue growth of 13.6%. Adjusted to exclude […]
Masimo wins expanded clearance for O3 oximetry device
Masimo (NSDQ:MASI) said today that its O3 regional oximetry device has been cleared for three additional indices — delta cHb, delta HHb, and delta O2Hb. These indices provide clinicians with greater visibility into changes in the underlying oxyhemoglobin and deoxyhemoglobin components used to calculate cerebral oxygen saturation, or rSO2, the Irvine, Calif.-based company said. The […]
Masimo gets in on Germany’s TNI Medical
Masimo (NSDQ:MASI) yesterday revealed an unspecified investment in Germany’s TNI Medical and its respiratory aid technology. Würzburg-based TNI developed the SoftFlow technology to deliver high-flow, warmed and humidified respiratory gases to pulmonary disease patients. It’s designed to provide room air or a mix of room air and oxygen without pneumatic systems, Masimo said. “The innovative products […]
Masimo lands CE Mark for infant hemoglobin monitor
Masimo (NSDQ:MASI) said it has won the CE Mark for a noninvasive and continuous hemoglobin monitor for newborn and infant patients weighing less than 3 kg (6.61 lbs.). SpHb uses the company’s Rainbow sensors, which allow clinicians to simultaneously measure multiple additional noninvasive parameters alongside SpHb, including oxygen saturation (SpO2) and methemoglobin (SpMet). Current […]
Masimo Q2 results exceed expectations
Masimo (NSDQ:MASI) announced second-quarter results today that beat The Street, raising its guidance for the rest of the year. The Irvine, Calif.–based patient monitoring technology company reported profits of $44.9 million, or $0.79 per share, on sales of $229.7 million for the three months ended June 29, with net income up 2.4% and sales increasing 13.6% compared […]
Masimo wins FDA clearance for neonatal O3 regional oximetry indication
Masimo (NSDQ:MASI) said today that it won FDA clearance for use of its O3 Regional Oximetry system with neonatal and infant patients. The Irvine, Calif.-based company’s technology uses near-infrared spectroscopy to assess the regional hemoglobin oxygen saturation of blood on both sides of the brain. The O3 sensors are now available in sizes to fit adult, […]
Masimo touts hemoglobin monitoring study, wins FDA nod for Radius PPG
Masimo (NSDQ:MASI) recently touted results from a study of its SpHb monitoring tech exploring its ability to detect possible anemia in patients undergoing spine or cytoreductive surgery, and said it won FDA 510(k) clearance for its Radius PPG tetherless sensor. The Irvine, Calif.-based company said that results from its SpHb tech were published in the journal […]
Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses
Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis. Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the […]
Masimo shares dip despite Q1 earnings beat
Shares in Masimo (NSDQ:MASI) have fallen today despite the medical diagnostic maker posting first quarter 2019 earnings that topped expectations on Wall Street. The Irvine, Calif.-based company posted profits of $49.3 million, or 87¢ per share, on sales of approximately $231.7 million for the three months ended March 30, seeing 8.1% growth on the bottom line […]
Masimo touts O3 cerebral oxygenation study results
Masimo (NSDQ:MASI) today released results from a study seeking to establish a normal range of values for cerebral oxygenation and explore the relationship between cerebral oxygenation and other physical and hemodynamic characteristics using Masimo’s O3 Regional Oximetry. Results from the study were published in the journal Anaesthesia and Intensive Care, the Irvine, Calif.-based company said. Masimo […]
- 1
- 2
- 3
- …
- 20
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube